Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Pharmacology

Pharmacology Research

Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.

Showing 281-290 of 639 results

PharmacologyNeurology

Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin-­associated proteins

Pharmacol Res Perspect, 2022 • April 9, 2022

The study investigates the paralytic effects of a novel botulinum toxin A (A/Chin) on rat gastrocnemius muscle, comparing its efficacy and duration to other BTX-A formulations with and without complex...

KEY FINDING: A/Chin demonstrates a rapid and consistent time-to-peak paralytic effect, reaching its peak on day 3 post-injection.

Read Summary
PharmacologyImmunologyGenetics

Development of Phage Cocktails to Treat E. coli Catheter-Associated Urinary Tract Infection and Associated Biofilms

Frontiers in Microbiology, 2022 • May 10, 2022

This study developed phage cocktails effective against E. coli strains isolated from urine of patients with spinal cord injury (SCI), which exhibit strong biofilm-forming properties, addressing the cha...

KEY FINDING: Nine phages were identified that individually decreased cell viability by >80% when added to biofilms of two E. coli strains in human urine.

Read Summary
Spinal Cord InjuryPharmacologyRehabilitation

Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report

Spinal Cord Series and Cases, 2022 • April 7, 2022

This case report highlights an instance of transient alterations in consciousness in a 43-year-old male with spinal cord injury following baclofen initiation, which resolved upon baclofen discontinuat...

KEY FINDING: Baclofen can cause transient alterations of consciousness in SCI patients, mimicking orthostatic hypotension.

Read Summary
PharmacologyNeurologyBiomedical

Insulin‑incubated palladium clusters promote recovery after brain injury

Journal of Nanobiotechnology, 2022 • June 4, 2022

The study introduces a novel biomimetic synthesis method for ultrasmall Pd nanoclusters (Pd@insulin) using insulin as a template, demonstrating its effectiveness in scavenging ROS and improving outcom...

KEY FINDING: Insulin-incubated palladium clusters (Pd@insulin) were successfully synthesized using a green biomimetic method and exhibited excellent multiple ROS-scavenging ability.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Notoginsenoside R1 alleviates spinal cord injury by inhibiting oxidative stress, neuronal apoptosis, and inflammation via activating the nuclear factor erythroid 2 related factor 2/heme oxygenase-1 signaling pathway

NeuroReport, 2022 • January 1, 2022

This study investigates the neuroprotective effect of Notoginsenoside R1 (NGR1) in rats with spinal cord injury (SCI) and its underlying mechanism. Results demonstrate that NGR1 administration reduces...

KEY FINDING: NGR1 administration enhances neurological function and mitigates tissue damage and motor neuron loss after SCI compared to the vehicle group.

Read Summary
PharmacologyEndocrinologyGenetics

Pharmacological Modulation of Melanocortin 1 Receptor Signaling by Mrap Proteins in Xenopus tropicalis

Frontiers in Endocrinology, 2022 • June 20, 2022

This study investigates the interaction between melanocortin 1 receptor (Mc1r) and melanocortin receptor-associated proteins (Mraps) in Xenopus tropicalis. The research combines in silico analysis wit...

KEY FINDING: xtMc1r interacts directly with xtMrap1 and xtMrap2 proteins on the plasma membrane, validated through co-immunoprecipitation and fluorescence.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Catalpol as a Component of Rehmannia glutinosa Protects Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis

Frontiers in Pharmacology, 2022 • July 8, 2022

This study investigates the neuroprotective effects of catalpol (CAT) on spinal cord injury (SCI) in rats. The research demonstrates that CAT promotes functional recovery in SCI rats by inhibiting ER ...

KEY FINDING: CAT has a restorative effect on the lower limb motor function of rats with SCI.

Read Summary
Spinal Cord InjuryAgingPharmacology

Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey

Spine Surg Relat Res, 2022 • December 27, 2021

This multicenter study investigated whether antiplatelet/anticoagulant (APAC) drugs affect blood loss during surgery for cervical spine trauma in elderly patients. The study found no significant incre...

KEY FINDING: APAC use in elderly patients was not significantly associated with surgical blood loss according to the IPTW method with propensity scoring or linear mixed model analyses.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

The effect of metformin on ameliorating neurological function deficits and tissue damage in rats following spinal cord injury: A systematic review and network meta-analysis

Frontiers in Neuroscience, 2022 • August 11, 2022

This systematic review examined the efficacy of metformin in treating spinal cord injuries (SCI) in rats. The review included 12 studies and analyzed the effects of metformin on neurological function ...

KEY FINDING: Metformin treatment was associated with increased Basso, Beattie, and Bresnahan (BBB) scores, indicating improved locomotor function in rats with SCI.

Read Summary
PharmacologyMental HealthBrain Injury

Correction to: Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury

Neuropsychopharmacology, 2022 • September 30, 2022

This article is a correction to a previously published study concerning the association of GFAP concentration and posttraumatic stress disorder in patients with mild traumatic brain injury. The correc...

KEY FINDING: The primary finding is a correction of the material measured; GFAP was measured in plasma, not serum, in the original study.

Read Summary
Previous
1...282930...64
Next